drugset / Trial / NCT06560775

Effects of Nigella Sativa on T Cells and Cytokine Profile in Pediatric SLE Patients

NCT06560775

Completed 32 enrolled University of Brawijaya
RandomizedParallel-groupSingle-blindSupportive care

Summary

The goal of this clinical trial is to learn if Nigella sativa oil works to improve SLEDAI Score in SLE pediatric student. It will also learn about the Treg, T helper cells, and cytokine of the patient. The main questions it aims to answer are: Does Nigella sativa oil lower the SLEDAI Score in pediatric patient? How does the effects of Nigella sativa oil on Treg cells, T helper cells, and cytokine in pediatric patient? Researchers will compare Nigella sativa oil group to a placebo group (a look-alike substance that contains no drug) to see if Nigella sativa oil works to treat SLE in pediatric patients. Participants will: Visit the clinic once in the beginning for pre treatment checkups. Take Nigella sativa oil or a placebo every day for 8 weeks. Visit the clinic once every 4 weeks for checkups. Visit the clinic after 8 weeks for post treatment checkups.

Timeline

Start
2022-01-03
Primary completion
2022-08-03
Completion
2023-01-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Nigella Sativa Oil Traditional medicine (herbal / TCM) 1 g